These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18582375)
21. Evaluation of Immunoglobulin G Responses to Rogier E; Moss DM; Chard AN; Trinies V; Doumbia S; Freeman MC; Lammie PJ Am J Trop Med Hyg; 2017 Feb; 96(2):312-318. PubMed ID: 27895279 [TBL] [Abstract][Full Text] [Related]
22. Prevalence and levels of IgG and IgM antibodies against Plasmodium falciparum and P. vivax in blood donors from Rondônia, Brazilian Amazon. Ferreira MU; Camargo LM; de Carvalho ME; Ninomia RT; Garcia LA; dos Santos FR Mem Inst Oswaldo Cruz; 1993; 88(2):263-9. PubMed ID: 8107588 [TBL] [Abstract][Full Text] [Related]
26. Immunogenicity of the Plasmodium vivax merozoite surface protein 1 paralog in the induction of naturally acquired antibody and memory B cell responses. Min HMK; Changrob S; Soe PT; Han JH; Muh F; Lee SK; Chootong P; Han ET Malar J; 2017 Aug; 16(1):354. PubMed ID: 28854974 [TBL] [Abstract][Full Text] [Related]
27. Plasmodium vivax VIR Proteins Are Targets of Naturally-Acquired Antibody and T Cell Immune Responses to Malaria in Pregnant Women. Requena P; Rui E; Padilla N; Martínez-Espinosa FE; Castellanos ME; Bôtto-Menezes C; Malheiro A; Arévalo-Herrera M; Kochar S; Kochar SK; Kochar DK; Umbers AJ; Ome-Kaius M; Wangnapi R; Hans D; Menegon M; Mateo F; Sanz S; Desai M; Mayor A; Chitnis CC; Bardají A; Mueller I; Rogerson S; Severini C; Fernández-Becerra C; Menéndez C; Del Portillo H; Dobaño C PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005009. PubMed ID: 27711158 [TBL] [Abstract][Full Text] [Related]
28. IgG antibodies to synthetic GPI are biomarkers of immune-status to both Plasmodium falciparum and Plasmodium vivax malaria in young children. França CT; Li Wai Suen CSN; Carmagnac A; Lin E; Kiniboro B; Siba P; Schofield L; Mueller I Malar J; 2017 Sep; 16(1):386. PubMed ID: 28946883 [TBL] [Abstract][Full Text] [Related]
29. Humoral immune responses to a recombinant Plasmodium vivax tryptophan-rich antigen among Plasmodium vivax-infected patients and its localization in the parasite. Siddiqui AA; Khan F; Sharma YD Appl Biochem Biotechnol; 2015 Feb; 175(4):2166-77. PubMed ID: 25467946 [TBL] [Abstract][Full Text] [Related]
30. Paroxysm serum from a case of Plasmodium vivax malaria inhibits the maturation of P. falciparum schizonts in vitro. Nagao Y; Chavalitshewinkoon-Petmitr P; Noedl H; Thongrungkiat S; Krudsood S; Sukthana Y; Nacher M; Wilairatana P; Looareesuwan S Ann Trop Med Parasitol; 2003 Sep; 97(6):587-92. PubMed ID: 14511557 [TBL] [Abstract][Full Text] [Related]
31. Immunological Cross-Reactivity between Malaria Vaccine Target Antigen P48/45 in Plasmodium vivax and P. falciparum and Cross-Boosting of Immune Responses. Cao Y; Bansal GP; Merino K; Kumar N PLoS One; 2016; 11(7):e0158212. PubMed ID: 27438603 [TBL] [Abstract][Full Text] [Related]
32. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil. Soares IS; Oliveira SG; Souza JM; Rodrigues MM Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957 [TBL] [Abstract][Full Text] [Related]
33. Differential antibody responses to Plasmodium falciparum and P. vivax circumsporozoite proteins in a human population. Burkot TR; Graves PM; Wirtz RA; Brabin BJ; Battistutta D; Cattani JA; Maizels RM; Alpers MP J Clin Microbiol; 1989 Jun; 27(6):1346-51. PubMed ID: 2666443 [TBL] [Abstract][Full Text] [Related]
34. Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection. Fesel C; Goulart LF; Silva Neto A; Coelho A; Fontes CJ; Braga EM; Vaz NM Malar J; 2005 Jan; 4():5. PubMed ID: 15661070 [TBL] [Abstract][Full Text] [Related]
35. The López C; Yepes-Pérez Y; Díaz-Arévalo D; Patarroyo ME; Patarroyo MA Front Cell Infect Microbiol; 2018; 8():156. PubMed ID: 29868512 [TBL] [Abstract][Full Text] [Related]
36. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti. Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796 [TBL] [Abstract][Full Text] [Related]
37. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Cerutti C; Boulos M; Coutinho AF; Hatab Mdo C; Falqueto A; Rezende HR; Duarte AM; Collins W; Malafronte RS Malar J; 2007 Mar; 6():33. PubMed ID: 17371598 [TBL] [Abstract][Full Text] [Related]
38. Cross-reactive cellular immune response to circumsporozoite proteins of Plasmodium vivax and P. falciparum in malaria-exposed individuals. Carvalho LH; Fontes CJ; Fernandes AA; Marinuzzi HC; Krettli AU Parasite Immunol; 1997 Feb; 19(2):47-59. PubMed ID: 9076807 [TBL] [Abstract][Full Text] [Related]
39. Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence. Baum E; Sattabongkot J; Sirichaisinthop J; Kiattibutr K; Davies DH; Jain A; Lo E; Lee MC; Randall AZ; Molina DM; Liang X; Cui L; Felgner PL; Yan G Malar J; 2015 Feb; 14():95. PubMed ID: 25849211 [TBL] [Abstract][Full Text] [Related]
40. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria. Chauhan VS; Chatterjee S; Johar PK Parasite Immunol; 1993 Apr; 15(4):239-42. PubMed ID: 7685076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]